SALMONELLA ENTERICA SPP.

PATHOGEN SAFETY DATA SHEET - INFECTIOUS SUBSTANCES

SECTION I - INFECTIOUS AGENT

NAME: Salmonella enterica spp. (formerly Salmonella choleraesuis)

SYNONYM OR CROSS REFERENCE: Salmonella enterica spp. - Salmonellosis.

Serotype Typhi - Typhoid fever, Enteric fever, Typhus abdominalis, Salmonella enterica serotype Typhi.

Serotype Choleraesuis - Salmonella septicaemia, hog cholera, hog typhoid, Samonella enterica serotype Choleraesuis, salmonellosis.

Serotype Paratyphi - Enteric fever, Paratyphoid fever, Salmonella Paratyphi type A, B and C, Salmonella enterica serotype Paratyphoid A, B and C.

CHARACTERISTICS: Salmonella enterica is one of two Salmonella species (enterica and bongori) and a member of the Enterobacteriaceae family ^{(1, 2)}. Salmonella enterica spp. is subdivided into 6 subspecies (enterica (I), salamae (II), arizonae (IIIa), diarizonae (IIIb), houtenae (IV) and indica (VI) ). The usual habitat for subspecies enterica (I) is warm-blooded animals ^(1-3). The usual habitat for subspecies II, IIIa, IIIb, IV and VI is cold-blooded animals and the environment ⁽²⁾. All species of Salmonella can infect humans. Salmonella enterica subspecies enterica has 2610 different serotypes; the most well known being serotypes Typhi, Paratyphi, Enteriditis, Typhimurium and Choleraesuis ⁽¹⁾. The serotypes are characterized by three surface antigens: the flagellar “H” antigen, the oligosaccharide “O” antigen and the polysaccharide “Vi” antigen (found in Typhi and Paratyphi serotypes) ⁽⁴⁾. Salmonella enterica is a facultative anaerobe and is a gram negative, motile and non-sporing rod that is 0.7-1.5 by 2.0-5.0 µm in size ^(4-6).

SECTION II – HAZARD IDENTIFICATION

PATHOGENICITY/TOXICITY: Salmonella enterica can cause four different clinical manifestations: gastroenteritis, bacteremia, enteric fever, and an asymptomatic carrier state ⁽⁷⁾. It is more common in children under the age of 5, adults 20-30 year olds, and patients 70 years or older ⁽⁷⁾.

Gastroenteritis: Gastroenteritis or “food poisoning” is usually characterized by sudden nausea, vomiting, abdominal cramps, diarrhea, headache chills and fever up to 39 ºC ^(6-9). The symptoms can be mild to severe and may last between 5-7 days ^{(7, 8)}. The Typhimurium serotype is the most common cause of gastroenteritis and there are an estimated 1.3 billion cases and 3 million deaths annually (1.4 million cases and 600 deaths in the US alone) due to non-typhoidal Salmonella ^{(2, 9, 10)}. In well resourced countries with low levels of invasive complications, the mortality rate due to non-typhoidal Salmonella is lower then 1% ⁽¹⁰⁾; however, in developing countries, the mortality rate can be as high as 24% ⁽¹⁰⁾.

Bacteremia: Bacteremia occurs in 3-10% of individuals infected with Salmonella enterica and certain serotypes (particularly serotype Choleraesuis) have higher mortality rates ^{(4, 11)}. Immunosuppressed individuals and patients with comorbid medical conditions (e.g. HIV-AIDS, diabetes, mellitus, malignancy, corrhosis, chronic granulomatous disease, sickle cell disease, lymphoproliferative disease, or collagen vascular disease) have a higher risk of developing bacteremia due to a Salmonella infection ^{(4, 7)}. Bacteremia can cause septic shock; endocarditis, especially in patients older then 50 or with heart conditions; infection of the aorta, especially in patients with pre-existing atherosclerotic disease; liver, spleen, and biliary tract infections in patients with underlying structural abnormalities; mesenteric lymphadenitis; osteomyelitis in long bones and vertebrae; urinary tract infection; pneumonia; pulmonary abscess; brain abscess; subdural and epidural empyema; meningitis; CNS infections (rarely); and death ^{(4, 7)}.

Enteric fever: Also known as typhoid fever, this infection is caused by serotypes Typhi and Paratyphi ^{(7, 12)}. Enteric fever is characterized by fever (rising within 72 hours after the onset of illness) and headache, brachycardia, faint rose-colored rash on the abdomen and chest, anorexia, abdominal pain, myalgias, malaise, diarrhea (more common in children) or constipation (more common in adults), hepatosplenomegaly, segmental ileus, meningismus, and neuropsychiatric manifestations ^{(4, 7)}. Less common symptoms are sore throat, cough, and bloody diarrhoea ⁽⁴⁾. Complications include myocarditis, encephalopathy, intravascular coagulation, infections of the biliary tree and intestinal tract, urinary tract infection, and metastatic lesions in bone, joints, liver, and meninges ^{(7, 8)}. The most severe complication (occurs in about 3% of patients) is haemorrhage due to perforations of the terminal ileum of proximal colon walls ^{(4, 7)}. If untreated, the fever can last for weeks; however, with proper antimicrobial therapy, patients usually recover within 10-14 days ⁽⁷⁾. The disease is milder in children and, if treated, has a mortality rate of less then 1%; untreated cases can have a mortality rate greater then 10 % ^{(2, 4)}.

EPIDEMIOLOGY: Infections with Salmonella enterica occur worldwide; however, certain diseases are more prevalent in different regions. Non-typhoid salmonellosis is more common in industrialized countries whereas enteric fever is mostly found in developing countries (with the most cases in Asia) ^{(4, 12)}. There are about 1.3 billion cases of non-typhoid salmonellosis worldwide each year and the WHO estimates that there are 17 million cases and over 500,000 deaths each year caused by typhoid fever ^{(4, 10)}. There is a peak in disease in the summer and fall, and it is most common in children ^{(2, 7, 9)}. In the developing world, salmonellosis contributes to childhood diarrhoea morbidity and mortality as bacteria are responsible for about 20% of cases ^{(4, 13)}. Epidemics of salmonellosis have been reported in institutions such as hospitals and nursing homes ⁽⁷⁾.

HOST RANGE: For serotypes causing non-typhoidal salmonellosis, the primary hosts are domestic and wild animals such as cattle, swine, poultry, wild birds, and pets (particularly reptiles) as well as flies ^{(8, 14, 15)}. Humans are usually the final host ⁽⁸⁾. For Salmonella Typhi, humans are the only known host ⁽⁷⁾.

INFECTIOUS DOSE: The infectious dose varies with the serotype. For non-typhoidal salmonellosis, the infectious dose is approximately 10³ bacilli ^{(4, 7)}. For enteric fever, the infectious dose is about 10⁵ bacilli by ingestion ^{(4, 6, 7)}. Patients with achlorhydria, depressed cell-mediated immunity, or who are elderly may become infected with at a lower infectious dose ^{(4, 7)}. The infectious dose may also be dependent on the level of acidity in the patient’s stomach ⁽⁴⁾.

MODE OF TRANSMISSION: Human infection usually occurs when consuming contaminated foods and water, contact with infected feces, as well as contact with infective animals, animal feed, or humans ^{(2, 4, 7, 8, 16)}. Foods that pose a higher risk include meat, poultry, milk products, and egg products ^(7-9). In hospitals, the bacteria have been spread by personnel in pediatric wards, either on their hands or on inadequately disinfected scopes ^{(5, 17)}. Flies can infect foods which can also be a risk for transmission to humans ^{(18, 19)}.

INCUBATION PERIOD: For non-typhoidal salmonellosis, the incubation period is variable, depends on the inoculum size, and usually ranges between 5 and 72 hours ⁽⁸⁾. For typhoid fever, the incubation period can be between 3 and 60 days, although most infections occur 7-14 days after contamination ⁽⁴⁾. The incubation period for typhoid fever is highly variable and depends on inoculum size, host susceptibility, and the bacterial strain ^{(2, 4)}.

COMMUNICABILITY: Humans can spread the disease for as long as they shed the bacterium in their feces ⁽²⁰⁾. Certain carriers shed the bacteria for years and 5 % of patients recovering from non-typhoidal salmonellosis can shed the bacteria for 20 weeks ⁽⁷⁾. Animals can have a latent or carrier state where they excrete the organism briefly, intermittently or persistently ⁽⁴⁾.

SECTION III - DISSEMINATION

RESERVOIR: For non-typhoidal salmonellosis, the reservoir hosts are domestic and wild animals such as cattle, swine, poultry, wild birds, flies and pets (particularly reptiles), as well as other humans (with the chronic carrier state) ^{(7, 8, 14, 18)}. For serotype Typhi, humans with the chronic carrier state are the only reservoir for the disease ^{(7, 14)}.

ZOONOSIS: Yes. Transmission between animals and humans occur when humans are in contact with infective animals and their feces ^{(2, 8)}.

VECTORS: Flies are a possible indirect vector as they may transmit the bacterium to foods ⁽¹⁹⁾.

SECTION IV – STABILITY AND VIABILITY

DRUG SUSCEPTIBILITY: Susceptible to chloramphenicol, ciproflaxin, amoxicillin, co-trimoxazole, trimethprim-sulfonamid, cephalosporins and norfloxacin ^{(4, 8)}. Some resistance to chloramphenicol has been reported and, in 1989, 32% of strains were multi-drug resistant ^{(2, 4, 17)}.

SUSCEPTIBILITY TO DISINFECTANTS: Gram negative bacteria are susceptible to 2-5% phenol, 1% sodium hypochlorite, 4% formaldehyde, 2% glutaraldehyde, 70% ethanol, 70% propanol, 2% peracetic acid, 3-6% hydrogen peroxide, quaternary ammonium compounds and iodophors; however, Salmonella spp. is resistant to nitrites ^{(6, 17)}.

PHYSICAL INACTIVATION: Susceptible to moist heat (121 ºC for at least 15 minutes) and dry heat (170 ºC for at least 1 hour) ⁽¹⁷⁾. Salmonella spp. can also be disinfected with ozone ⁽¹⁷⁾.

SURVIVAL OUTSIDE HOST: Serotype Choleraesuis can survive in wet swine feces for at least 3 months and in dry swine feces for at least 13 months ⁽²¹⁾. Serotype Dublin can survive in feces spread on concrete, rubber, and polyester for almost six years ⁽¹⁷⁾. Serotype Typhimurium can survive in cattle slurry for 19-60 days, cattle manure for 48 days, soil for 231 days, and water for up to 152 days ^{(22, 23)}. Flies have been shown to excrete certain serotypes for 8 days and bed bugs can excrete bacilli for up to 21 days ^{(15, 24)}. Certain serotypes have been shown to survive on fingertips for up to 80 minutes, depending on the inoculum size ⁽²⁵⁾. Salmonella serotypes have been found to live up to 63 days on lettuce, 231 days on parsley, 32 weeks in pecans, 10 months on refrigerated cheddar cheese, 9 months in butter, up to 63 days in frozen yogurt, and up to 20 weeks on frozen minced beef and chicken ^(26-28).

SECTION V – FIRST AID / MEDICAL

SURVEILLANCE: Monitor for symptoms. Confirm diagnosis by isolation from stool or blood and by serotyping to identify the serotype ^{(7, 8)}.

Note: All diagnostic methods are not necessarily available in all countries.

FIRST AID/TREATMENT: Treatment depends on the clinical symptoms presented by the patient.

Gastrotenteritis: Fluid and electrolyte replacement as well as control of the nausea and vomiting are the usual treatments for these symptoms ^{(7, 8)}. Antibiotic treatment is not usually used; however, it may be necessary for neonates, children, the elderly, and the immunosuppressed, in which case ciproflaxin, co-trimoxazole, ampicillin, and cephalosporins may be used ^{(4, 7, 8)}.

Bacteremia: Antibiotic treatment is used to treat bacteremia (e.g. ciproflaxin, co-trimoxazole, ampicillin, or cephalosporins), especially for neonates, children, the elderly, and the immunosuppressed ^{(7, 8)}.

Enteric fever: Chloramphenicol is the most common antibiotic used for enteric fever although ampicillin, trimethoprim-sulfonamid, cephalosporins, ciproflaxin, and norfloxacin are also being used to treat the disease ^{(4, 7)}.

Asymptomatic carrier state: Carriers can be treated with ciproflaxin in order to reduce the spread of the infectious agent ⁽⁸⁾.

IMMUNIZATION: There is no vaccine to prevent non-typhoidal salmonellosis currently available ⁽¹⁴⁾. Three vaccines (2 parenteral and 1 oral) are licensed for use in the US and should be considered for those working with serotype Typhi in a laboratory setting and for travellers who are going to spend extended periods of time in endemic areas ^{(4, 7, 14)}. The vaccines available offer moderate protection against typhoid fever; however, they do not protect against the Paratyphi serotype of the bacterium ⁽¹²⁾. It has been shown that a live oral vaccine protects 70% of children inoculated in endemic areas ⁽⁷⁾. Vaccination is not recommended for pregnant women and patients with HIV-AIDS ⁽²⁹⁾.

PROPHYLAXIS: Antibiotics can be used as prophylaxis in at-risk individuals (for example neonates and the immunocompromised) ⁽⁷⁾. Clean water supplies, sanitation, and treatment of carriers are the best prophylactic measures to prevent the spread of enteric fever in endemic areas ⁽⁷⁾.

SECTION VI - LABORATORY HAZARDS

LABORATORY-ACQUIRED INFECTIONS: Until 1974, 258 cases and 20 deaths due to laboratory-acquired typhoid fever were reported ⁽⁶⁾. 48 cases of salmonellosis were reported until 1976 ⁽²⁾. 64 cases and 2 deaths due to Salmonella spp. infections were reported between 1979 and 2004, most of them associated with S. Typhi ⁽³⁰⁾.

SOURCES/SPECIMENS: All Salmonella enterica subspecies (with the exception of serotype Typhi) are found in blood, urine, feces, food and feed and environmental materials ⁽¹⁴⁾. Serotype Typhi is found in blood, urine, feces and bile ⁽¹⁴⁾.

PRIMARY HAZARDS: Primary hazards when working with Salmonella enterica are accidental parenteral inoculation and ingestion ⁽¹⁴⁾. The risk associated with aerosol exposure is not yet known ⁽¹⁴⁾.

SPECIAL HAZARDS: Infected animals are a risk (for all serotypes except Typhi and Paratyphi) ⁽¹⁴⁾.

SECTION VII – EXPOSURE CONTROLS / PERSONAL PROTECTION

RISK GROUP CLASSIFICATION: Risk group 2 ⁽³¹⁾. The risk group associated with Salmonella enterica ssp. reflects the species as a whole, but does not necessarily reflect the risk group classification of every subspecies.

CONTAINMENT REQUIREMENTS: Containment level 2 practices, safety equipment and facilities are recommended for work involving infectious or potentially infectious materials, animals, or cultures. Containment level 3 practices and procedures are recommended for activities with serotype typhi that might generate aerosols or large quantities of organisms. These containment requirements apply to the species as a whole, and may not apply to each subspecies within the species.

PROTECTIVE CLOTHING: Lab coat. Gloves when direct skin contact with infected materials or animals is unavoidable. Eye protection must be used where there is a known or potential risk of exposure to splashes ⁽³²⁾.

OTHER PRECAUTIONS: All procedures that may produce aerosols, involve high concentrations or large volumes should be conducted in a biological safety cabinet (BSC). The use of needles, syringes and other sharp objects should be strictly limited. The use of needles, syringes, and other sharp objects should be strictly limited. Additional precautions should be considered with work involving animals or large scale activities ⁽³²⁾.

SECTION VIII - HANDLING AND STORAGE

SPILLS: Allow aerosols to settle, then, wearing protective clothing, gently cover the spill with absorbent paper towel and apply appropriate disinfectant, starting at the perimeter and working towards the center. Allow sufficient contact time before starting the clean up ⁽³²⁾.

DISPOSAL: All wastes should be decontaminated before disposal either by steam sterilization, incineration or chemical disinfection ⁽³²⁾.

STORAGE: The infectious agent should be stored in a sealed and identified container ⁽³²⁾.

SECTION IX – REGULATORY AND OTHER INFORMATION

REGULATORY INFORMATION: The import, transport, and use of pathogens in Canada is regulated under many regulatory bodies, including the Public Health Agency of Canada, Health Canada, Canadian Food Inspection Agency, Environment Canada, and Transport Canada. Users are responsible for ensuring they are compliant with all relevant acts, regulations, guidelines, and standards.

UPDATED: August 2010

PREPARED BY: Pathogen Regulation Directorate, Public Health Agency of Canada.

Although the information, opinions and recommendations contained in this Pathogen Safety Data Sheet are compiled from sources believed to be reliable, we accept no responsibility for the accuracy, sufficiency, or reliability or for any loss or injury resulting from the use of the information. Newly discovered hazards are frequent and this information may not be completely up to date.

Copyright ©

Public Health Agency of Canada, 2010

Canada

REFERENCES:

1. Su, L. H., & Chiu, C. H. (2007). Salmonella: clinical importance and evolution of nomenclature. Chang Gung Medical Journal, 30(3), 210-219.
    
2. Murray, P. R., Baron, E. J., Jorgensen, J. H., Landry, M. L., & Pfaller, M. A. (Eds.). (2007). Manual of Clinical Microbiology (9th ed.). Washington: ASM Press.
    
3. Porwollik, S., Boyd, E. F., Choy, C., Cheng, P., Florea, L., Proctor, E., & McClelland, M. (2004). Characterization of Salmonella enterica subspecies I genovars by use of microarrays. Journal of Bacteriology, 186(17), 5883-5898. doi:10.1128/JB.186.17.5883-5898.2004
    
4. Bronze, M.S., and Greenfield, R.A (Ed.). (2005). Biodefence Principles and Pathogens horizon bioscience.
    
5. Garrity, G. M., Brenner, D. J., Krieg, N. R., & Staley, J. T. (Eds.). (2005.). Bergey's Manual of Systematic Bacteriology. (2nd ed.). New York: Springer.
    
6. Collins, C. H., & Kennedy, D. A. (Eds.). (1983). Laboratory-acquired Infections (4th ed.). Oxford: Butterworth-Heinermann.
    
7. Ryan, K. J., & Ray, C. G. (Eds.). (2004.). Sherris Medical Microbiology: An Introduction to Infectious Disease. (Fourth Edition. ed.). New York.: McGraw-Hill.
    
8. Krauss, H., Weber, A., Appel, M., Enders, B., Isenberg, H. D., Schiefer, H. G., Slenczka, W., von Graevenitz, A., & Zahner, H. (Eds.). (2003). Zoonoses Infectious Diseases Transmissible from Animals to Humans (3rd ed.). Washington: ASM press.
    
9. Brock, T. D., Madigan, M. T., Martinko, J. M., & Parker, J. (2000). Biology of Microorganisms (9th ed.). New Jersey, USA: Prentice-Hall, Inc.
    
10. Chimalizeni, Y., Kawaza, K., & Molyneux, E. (2010). The epidemiology and management of non typhoidal salmonella infections. Advances in Experimental Medicine and Biology, 659, 33-46. doi:10.1007/978-1-4419-0981-7_3
     
11. Woods, D. F., Reen, F. J., Gilroy, D., Buckley, J., Frye, J. G., & Boyd, E. F. (2008). Rapid multiplex PCR and real-time TaqMan PCR assays for detection of Salmonella enterica and the highly virulent serovars Choleraesuis and Paratyphi C. Journal of Clinical Microbiology, 46(12), 4018-4022. doi:10.1128/JCM.01229-08
     
12. Connor, B. A., & Schwartz, E. (2005). Typhoid and paratyphoid fever in travellers. The Lancet Infectious Diseases, 5(10), 623-628. doi:10.1016/S1473-3099(05)70239-5
     
13. Koletzko, S., & Osterrieder, S. (2009). Acute infectious diarrhea in children. Deutsches Arzteblatt International, 106(33), 539-47; quiz 548. doi:10.3238/arztebl.2009.0539
     
14. Richmond, J. Y., & McKinney, R. W. (Eds.). (1999). Biosafety in Microbiological and Biomedical Laboratories (4th ed.). Washington: CDC-NIH.
     
15. Greenberg, B., Kowalski, J. A., & Klowden, M. J. (1970). Factors affecting the transmission of salmonella by flies: natural resistance to colonization and bacterial interference. Infection and Immunity, 2(6), 800-809.
     
16. Davies, P. R., Scott Hurd, H., Funk, J. A., Fedorka-Cray, P. J., & Jones, F. T. (2004). The role of contaminated feed in the epidemiology and control of Salmonella enterica in pork production. Foodborne Pathogens and Disease, 1(4), 202-215. doi:10.1089/fpd.2004.1.202
     
17. Block, S. S. (Ed.). (2001). Disinfection, Sterilization, and Preservation (5th ed.). Philidelphia: Lippincott Williams & Wilkins.
     
18. GREENBERG, B. (1964). Experimental Transmission of Salmonella Typhimurium by Houseflies to Man. American Journal of Hygiene, 80, 149-156.
     
19. Ostrolenk, M., & Welch, H. (1942). The House Fly as a Vector of Food Poisoning Organisms in Food Producing Establishments. American Journal of Public Health and the Nation's Health, 32(5), 487-494.
     
20. Emerson, H. (1939). State Procedures for Communicable Disease Control. American Journal of Public Health and the Nation's Health, 29(7), 701-708.
     
21. Gray, J. T., & Fedorka-Cray, P. J. (2001). Survival and infectivity of Salmonella choleraesuis in swine feces. Journal of Food Protection, 64(7), 945-949.
     
22. Guan, T. Y., & Holley, R. A. (2003). Pathogen survival in swine manure environments and transmission of human enteric illness--a review. Journal of Environmental Quality, 32(2), 383-392.
     
23. Islam, M., Morgan, J., Doyle, M. P., Phatak, S. C., Millner, P., & Jiang, X. (2004). Persistence of Salmonella enterica serovar typhimurium on lettuce and parsley and in soils on which they were grown in fields treated with contaminated manure composts or irrigation water. Foodborne Pathogens and Disease, 1(1), 27-35. doi:10.1089/153531404772914437
     
24. Blow, J. A., Turell, M. J., Silverman, A. L., & Walker, E. D. (2001). Stercorarial shedding and transtadial transmission of hepatitis B virus by common bed bugs (Hemiptera: Cimicidae). Journal of Medical Entomology, 38(5), 694-700.
     
25. Pether, J. V., & Gilbert, R. J. (1971). The survival of salmonellas on finger-tips and transfer of the organisms to foods. The Journal of Hygiene, 69(4), 673-681.
     
26. Barrell, R. A. (1988). The survival and recovery of Salmonella typhimurium phage type U285 in frozen meats and tryptone soya yeast extract broth. International Journal of Food Microbiology, 6(4), 309-316.
     
27. Beuchat, L. R., & Heaton, E. K. (1975). Salmonella survival on pecans as influenced by processing and storage conditions. Applied Microbiology, 29(6), 795-801.
     
28. el-Gazzar, F. E., & Marth, E. H. (1992). Salmonellae, salmonellosis, and dairy foods: a review. Journal of Dairy Science, 75(9), 2327-2343.
     
29. Conlon, C. P. (1993). The immunocompromised traveller. British Medical Bulletin, 49(2), 412-422.
     
30. Fleming D & Hunt D (Ed.). (2006). Biological Safety Principles and Practices (4th ed.). Washington: ASM Press.
     
31. Human Pathogens and Toxins Act. S.C. 2009, c. 24. Government of Canada, Second Session, Fortieth Parliament, 57-58 Elizabeth II, 2009, (2009).
     
32. Public Health Agency of Canada. (2004). In Best M., Graham M. L., Leitner R., Ouellette M. and Ugwu K. (Eds.), Laboratory Biosafety Guidelines (3rd ed.). Canada: Public Health Agency of Canada.